NCT07023406

Brief Summary

Despite much research that has focused on enhancing type 2 diabetes mellitus (T2DM) health outcomes for high burden populations, more remains to be done. There is a need to develop practical approaches that not only equip people with knowledge about T2DM self-management, but also help them mitigate the adverse social determinants of health (SDOH) that are fueling the burgeoning numbers of people in the United States with T2DM and that are preventing them from practicing healthful behaviors. This study will examine an intervention named 'Disfrutando' that strives to help people prevent and manage T2DM.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
31

participants targeted

Target at P25-P50 for not_applicable

Timeline
1mo left

Started Aug 2025

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress87%
Aug 2025Jul 2026

First Submitted

Initial submission to the registry

May 29, 2025

Completed
19 days until next milestone

First Posted

Study publicly available on registry

June 17, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

August 1, 2025

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 15, 2026

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2026

Expected
Last Updated

May 7, 2026

Status Verified

June 1, 2025

Enrollment Period

10 months

First QC Date

May 29, 2025

Last Update Submit

April 30, 2026

Conditions

Keywords

Participatory ResearchT2DMHigh-Burden Populations

Outcome Measures

Primary Outcomes (1)

  • Glucose (Blood Sugar) Control

    Name of measurement: Hemoglobin A1c (HbA1C) How measured/assessed: HbA1C is a biomedical test that provides average glucose (blood sugar) level over the past 8 to 12 weeks and is used to help manage diabetes. Glucose (blood sugar) control will be evaluated using the A1CNow Self Check device. This FDA-cleared device is sold over the counter and is a portable, self-check test that is self-administered using a small fingerstick blood sample. Results are obtained in 5 minutes.

    Hemoglobin A1C will be measured at baseline (pre-intervention), 12 weeks, and 6 months.

Secondary Outcomes (2)

  • Change in Body Weight

    Body weight will be measured weekly for 6 weeks, at 12 weeks, and at 6 months. The same scale will be used at all time points.

  • Self-efficacy for diabetes self-care management

    Self-efficacy will be measured at pre-intervention, 12 weeks, and 6 months

Study Arms (2)

Intervention Group

EXPERIMENTAL

Behavioral Intervention

Behavioral: Disfrutando

Waitlist Group

EXPERIMENTAL

This arm will receive the intervention after the waitlist period

Behavioral: Disfrutando

Interventions

DisfrutandoBEHAVIORAL

Disfrutando is a six-week, weekly intervention with a booster intervention at week 12. Intervention content includes glucose control with individual goals, glucose monitoring and glucometer practice, healthy eating demonstrations, benefits of physical activity, prevention and management of T2DM. The intervention has a strong focus on mitigating barriers and challenges to diabetes self-care management.

Intervention GroupWaitlist Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Hemoglobin A1C of 5.7 or higher

You may not qualify if:

  • Hemoglobin A1C of 5.6 or lower

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

University of Missouri

Columbia, Missouri, 65211, United States

RECRUITING

Holy Cross Church

Kansas City, Missouri, 64123, United States

RECRUITING

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Central Study Contacts

Maithe Enriquez, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Randomized, controlled, waitlisted, design
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor in Nursing

Study Record Dates

First Submitted

May 29, 2025

First Posted

June 17, 2025

Study Start

August 1, 2025

Primary Completion

May 15, 2026

Study Completion (Estimated)

July 31, 2026

Last Updated

May 7, 2026

Record last verified: 2025-06

Locations